Industry Insights
Proxxi’s October Newsletter
In autumn 2020, many nations in the northern hemisphere saw an increase in cases of COVID-19. How will we fare this fall? Last month we shared the first posts in our vaccine and Delta blog series. This month, we bring you more of what you need to know.
The Covid-19 Vaccine: The Israel Case Study - Part 3
Israel was the first nation to vaccinate the majority of its population. As such, the rest of the world can look to it to better understand the progression of “getting back to normal”. Organizations can take note of their experience and apply lessons learned to their own COVID-19 safety plan.
The Covid-19 Vaccine: Herd Immunity - Part 2
“Herd immunity” became a rallying cry around the COVID-19 vaccine. With herd immunity we could feasibly return to normal without fear of outbreaks. Is it still possible? And how does this impact the end of the COVID-19 pandemic?
The Delta Variant: Why Is This Variant Such Big News? - Part 1
In recent months, the Delta variant has become the most prominent COVID-19 variant globally. Having first surfaced in India in October 2020, the variant quickly spread world-wide. As a result of the Delta variant, many organizations and countries have had to revisit their COVID-19 policies.
Proxxi’s April Newsletter - 2021
Did you know that April 7th is World Health Day? Supporting the health and safety of business and their employees is Proxxi’s key driver. We strive to bring you pertinent information for workplace health and safety topics in our monthly newsletters, and April is no exception.
Protecting On-Site Workers - A Case Study with The ExOne Company
We had an opportunity to check in with our Proxxi Contact customer, The ExOne Company, at the end of February. We wanted to ask Sarah Calabrese, the Environmental Health & Safety Coordinator North America at ExOne, how the deployment of the Proxxi Contact solution that she spearheaded was going. This EH&S Coordinator explained how she is protecting some of their most valuable on-site workers.
Proxxi’s March Newsletter - 2021
This March marks the one year mark of Covid-19 being declared a global pandemic. A lot of change has happened over the past year, but here at Proxxi we will want to ensure our customers are well informed about the topics that matter to them. In this newsletter we will be focusing on how you can improve your organization’s workplace safety plan.
HealthWell Solutions: How Will the Covid-19 Vaccine Affect Return to Work Strategies?
As more employees are now getting vaccinated, some questions are beginning to arise for employers to implement safety and COVID return to work strategies for their employees. Research is still underway to determine the effectiveness of COVID antibodies and if the vaccines will prevent those who have received it from spreading Covid-19.
Creating a COVID-19 Action Plan - A Case Study with Johns Manville
In the beginning of February, Proxxi had the opportunity to chat with Casey McClain, Senior EHS Specialist, and Lyndsy Malark, Pandemic Coordinator, at Johns Manville’s Plattsburgh, New York facility. We discussed how they have been managing health and safety measures over the last year in their upper New York State manufacturing facility.
Creating a Workplace Plan - A Case Study with a Clean Energy Company
One of our customers is a global group that develops and manages sustainable infrastructure solutions, especially in renewable energy. Their business spans the entire value chain, from design and construction through to operation and maintenance. They are aware of the importance of having a workplace safety program that is well thought out, comprehensive, and effective.
Creating a Safe Workplace
With our products, our goal is to make workplaces safer for employees and for organizations. With many of us back to working on-site, we wanted to create a list of different ways that you can keep your workplace safe during the Covid-19 pandemic. Some of the items on this list may not be required by your local health authority, but could potentially help in reducing the risk of spreading Covid-19.